The Wiskott-Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets

Journal of Leukocyte Biology

Volumn 88, Issue 5, 2010, Pages 1031-1040

  De Meester, Julie ^a   Calvez, Ronan ^a   Valitutti, Salvatore ^a   Dupré, Loïc ^a  

^a INSERM   (France)

Author keywords

Cytotoxic T cells; Immunodeficiency diseases; Tumor immunity

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; LENTIVIRUS VECTOR; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DOWN REGULATION; EPSTEIN BARR VIRUS; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LYMPHOCYTE PROLIFERATION; LYSIS; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; WISKOTT ALDRICH SYNDROME;

B-LYMPHOCYTES; BURKITT LYMPHOMA; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MICROSCOPY, CONFOCAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

HUMAN HERPESVIRUS 4;

EID: 78649617600     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0410197     Document Type: Article

References (47)

1. Derry, J. M., Ochs, H. D., Francke, U. (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78, 635-644.
2. Ochs, H. D., Thrasher, A. J. (2006) The Wiskott-Aldrich syndrome. J. Allergy Clin. Immunol. 117, 725-738.
3. Bosticardo, M., Marangoni, F., Aiuti, A., Villa, A., Grazia Roncarolo, M. (2009) Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 113, 6288-6295.
4. Villa, A., Notarangelo, L., Macchi, P., Mantuano, E., Cavagni, G., Brugnoni, D., Strina, D., Patrosso, M. C., Ramenghi, U., Sacco, M. G., et al. (1995) X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat. Genet. 9, 414-417.
5. Imai, K., Morio, T., Zhu, Y., Jin, Y., Itoh, S., Kajiwara, M., Yata, J., Mizutani, S., Ochs, H. D., Nonoyama, S. (2004) Clinical course of patients with WASP gene mutations. Blood 103, 456-464. (Pubitemid 38140073)
6. Higgs, H. N., Pollard, T. D. (2000) Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J. Cell Biol. 150, 1311-1320.
7. Kim, A. S., Kakalis, L. T., Abdul-Manan, N., Liu, G. A., Rosen, M. K. (2000) Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404, 151-158.
8. Zicha, D., Allen, W. E., Brickell, P. M., Kinnon, C., Dunn, G. A., Jones, G. E., Thrasher, A. J. (1998) Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101, 659-665.
9. Haddad, E., Zugaza, J. L., Louache, F., Debili, N., Crouin, C., Schwarz, K., Fischer, A., Vainchenker, W., Bertoglio, J. (2001) The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood 97, 33-38.
10. Dovas, A., Gevrey, J-C., Grossi, A., Park, H., Abou-Kheir, W., Cox, D. (2009) Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. J. Cell Sci. 122, 3873-3882.
11. Linder, S., Nelson, D., Weiss, M., Aepfelbacher, M. (1999) Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl. Acad. Sci. USA 96, 9648-9653. (Pubitemid 29398786)
12. Burns, S., Thrasher, A. J., Blundell, M. P., Machesky, L., Jones, G. E. (2001) Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 98, 1142-1149.
13. Dupre, L., Aiuti, A., Trifari, S., Martino, S., Saracco, P., Bordignon, C., Roncarolo, M. G. (2002) Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17, 157-166.
14. Cannon, J. L., Burkhardt, J. K. (2004) Differential roles for Wiskott-Aldrich syndrome protein in immune synapse formation and IL-2 production. J. Immunol. 173, 1658-1662.
15. Orange, J. S., Harris, K. E., Andzelm, M. M., Valter, M. M., Geha, R. S., Strominger, J. L. (2003) The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc. Natl. Acad. Sci. USA 100, 14151-14156.
16. Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B., Cambi, A., Figdor, C., Vainchenker, W., Galy, A., Caignard, A., Zitvogel, L. (2004) NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104, 3267-3275.
17. Bouma, G., Burns, S., Thrasher, A. J. (2007) Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells. Blood 110, 4278-4284.
18. Pulecio, J., Tagliani, E., Scholer, A., Prete, F., Fetler, L., Burrone, O. R., Benvenuti, F. (2008) Expression of Wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cells. J. Immunol. 181, 1135-1142.
19. Morales-Tirado, V., Johannson, S., Hanson, E., Howell, A., Zhang, J., Siminovitch, K. A., Fowell, D. J. (2004) Cutting edge: selective requirement for the Wiskott-Aldrich syndrome protein in cytokine, but not chemokine, secretion by CD4+ T cells. J. Immunol. 173, 726-730.
20. Trifari, S., Sitia, G., Aiuti, A., Scaramuzza, S., Marangoni, F., Guidotti, L. G., Martino, S., Saracco, P., Notarangelo, L. D., Roncarolo, M. G., Dupre, L. (2006) Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J. Immunol. 177, 7451-7461.
21. Astrakhan, A., Ochs, H. D., Rawlings, D. J. (2009) Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J. Immunol. 182, 7370-7380.
22. Locci, M., Draghici, E., Marangoni, F., Bosticardo, M., Catucci, M., Aiuti, A., Cancrini, C., Marodi, L., Espanol, T., Bredius, R. G., Thrasher, A. J., Schulz, A., Litzman, J., Roncarolo, M. G., Casorati, G., Dellabona, P., Villa, A. (2009) The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J. Exp. Med. 206, 735-742.
23. Humblet-Baron, S., Sather, B., Anover, S., Becker-Herman, S., Kasprowicz, D. J., Khim, S., Nguyen, T., Hudkins-Loya, K., Alpers, C. E., Ziegler, S. F., Ochs, H., Torgerson, T., Campbell, D. J., Rawlings, D. J. (2007) Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J. Clin. Invest. 117, 407-418.
24. Marangoni, F., Trifari, S., Scaramuzza, S., Panaroni, C., Martino, S., Notarangelo, L. D., Baz, Z., Metin, A., Cattaneo, F., Villa, A., Aiuti, A., Battaglia, M., Roncarolo, M. G., Dupre, L. (2007) WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J. Exp. Med. 204, 369-380.
25. Maillard, M. H., Cotta-de-Almeida, V., Takeshima, F., Nguyen, D. D., Michetti, P., Nagler, C., Bhan, A. K., Snapper, S. B. (2007) The Wiskott- Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J. Exp. Med. 204, 381-391. (Pubitemid 46294553)
26. Park, J. Y., Shcherbina, A., Rosen, F. S., Prodeus, A. P., Remold-O'Donnell, E. (2005) Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin. Exp. Immunol. 139, 297-305.
27. Westerberg, L. S., de la Fuente, M. A., Wermeling, F., Ochs, H. D., Karlsson, M. C., Snapper, S. B., Notarangelo, L. D. (2008) WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. Blood 112, 4139-4147.
28. Meyer-Bahlburg, A., Becker-Herman, S., Humblet-Baron, S., Khim, S., Weber, M., Bouma, G., Thrasher, A. J., Batista, F. D., Rawlings, D. J. (2008) Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood 112, 4158-4169.
29. Prlic, M., Williams, M. A., Bevan, M. J. (2007) Requirements for CD8 T-cell priming, memory generation and maintenance. Curr. Opin. Immunol. 19, 315-319.
30. Sherwood, G., Blaese, R. M. (1973) Phytohemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS). Clin. Exp. Immunol. 13, 515-520.
31. Vilmer, E., Lenoir, G. M., Virelizier, J. L., Griscelli, C. (1984) Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and Ataxia telangiectasia. Clin. Exp. Immunol. 55, 249-256.
32. Herrmann, T., MacDonald, H. R. (1993) The CD8 T cell response to Staphylococcal enterotoxins. Semin. Immunol. 5, 33-39.
33. Trifari, S., Scaramuzza, S., Catucci, M., Ponzoni, M., Mollica, L., Chiesa, R., Cattaneo, F., Lafouresse, F., Calvez, R., Vermi, W., Medicina, D., Castiello, M. C., Marangoni, F., Bosticardo, M., Doglioni, C., Caniglia, M., Aiuti, A., Villa, A., Roncarolo, M. G., Dupre, L. (2010) Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J. Allergy Clin. Immunol. 125, 439-448 e8.
34. Esquerre, M., Tauzin, B., Guiraud, M., Muller, S., Saoudi, A., Valitutti, S. (2008) Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-β-dependent mechanism. Proc. Natl. Acad. Sci. USA 105, 2550-2555. (Pubitemid 351520551)
35. Marangoni, F., Bosticardo, M., Charrier, S., Draghici, E., Locci, M., Scaramuzza, S., Panaroni, C., Ponzoni, M., Sanvito, F., Doglioni, C., Liabeuf, M., Gjata, B., Montus, M., Siminovitch, K., Aiuti, A., Naldini, L., Dupre, L., Roncarolo, M.G., Galy, A., Villa, A. (2009) Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol. Ther. 17, 1073-1082.
36. Orange, J. S., Ramesh, N., Remold-O'Donnell, E., Sasahara, Y., Koopman, L., Byrne, M., Bonilla, F. A., Rosen, F. S., Geha, R. S., Strominger, J. L. (2002) Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc. Natl. Acad. Sci. USA 99, 11351-11356.
37. Gomez, T. S., Kumar, K., Medeiros, R. B., Shimizu, Y., Leibson, P. J., Billadeau, D. D. (2007) Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse. Immunity 26, 177-190.
38. Gismondi, A., Cifaldi, L., Mazza, C., Giliani, S., Parolini, S., Morrone, S., Jacobelli, J., Bandiera, E., Notarangelo, L., Santoni, A. (2004) Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood 104, 436-443.
39. Sims, T. N., Soos, T. J., Xenias, H. S., Dubin-Thaler, B., Hofman, J. M., Waite, J. C., Cameron, T. O., Thomas, V. K., Varma, R., Wiggins, C. H., Sheetz, M. P., Littman, D. R., Dustin, M. L. (2007) Opposing effects of PKCθ and WASp on symmetry breaking and relocation of the immunological synapse. Cell 129, 773-785.
40. Huang, W., Ochs, H. D., Dupont, B., Vyas, Y. M. (2005) The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-κ B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement. J. Immunol. 174, 2602-2611.
41. Beal, A. M., Anikeeva, N., Varma, R., Cameron, T. O., Norris, P. J., Dustin, M. L., Sykulev, Y. (2008) Protein kinase C θ regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL. J. Immunol. 181, 4815-4824.
42. Stinchcombe, J. C., Majorovits, E., Bossi, G., Fuller, S., Griffiths, G. M. (2006) Centrosome polarization delivers secretory granules to the immunological synapse. Nature 443, 462-465. (Pubitemid 44477283)
43. Stinchcombe, J. C., Bossi, G., Booth, S., Griffiths, G. M. (2001) The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15, 751-761.
44. Ramsay, A. G., Johnson, A. J., Lee, A. M., Gorgun, G., Le Dieu, R., Blum, W., Byrd, J. C., Gribben, J. G. (2008) Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J. Clin. Invest. 118, 2427-2437.
45. Andreansky, S., Liu, H., Turner, S., McCullers, J. A., Lang, R., Rutschman, R., Doherty, P. C., Murray, P. J., Nienhuis, A. W., Strom, T. S. (2005) WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp. Hematol. 33, 443-451.
46. Le Bras, S., Massaad, M., Koduru, S., Kumar, L., Oyoshi, M. K., Hartwig, J., Geha, R. S. (2009) WIP is critical for T cell responsiveness to IL-2. Proc. Natl. Acad. Sci. USA 106, 7519-7524.
47. Fischer, A., Latour, S., de Saint Basile, G. (2007) Genetic defects affecting lymphocyte cytotoxicity. Curr. Opin. Immunol. 19, 348-353.